Soon after initial identification of PD-L1, analysis of renal cell carcinoma (RCC) patient survival outcomes following nephrectomy identified that patients with high expression levels of PD-L1 on either RCC tumor cells, RCC tumor infiltrating lymphocytes, or both, were at significantly increased risk of death from aggressive tumor progression (73). Here, CD274 is linked to renal cell carcinoma.